We use cookies to give you the best experience and to help improve our website

Find out what cookies we use and how to disable them

ISO/NP TS 25364-4 - Analytical chemistry matters associated with ISO 10993-18 — Part 4: Critical aspects of extract viability in extractables and leachables testing using non-targeted analysis (NTA)

Source:
ISO
Committee:
CH/194 - Biological evaluation of medical devices
Categories:
Information management | Standardization. General rules
Comment period start date:
Comment period end date:

Comment by:

Scope

This document establishes best practice recommendations for:

 — processing extracts for instrumental analysis;

— recognizing and addressing compromised extracts.

This document can be used in conjunction with ISO 10993-18.

Purpose

ISO 10993-18:2020, specifies a framework for the discovery, identification, and quantification of extractable and/or leachable constituents of a medical device, allowing the identification of biological hazards and the estimation and control of biological risks from material constituents. ISO 10993-18: 2020 reflects and establishes those practical, achievable, and science-based best practices for leachables and extractables identification and quantification for which a consensus in the community of practice could be achieved. This document was written to augment ISO 10993-18:2020.

Comment on proposal

Required form fields are indicated by an asterisk (*) character.


Please email further comments to: debbie.stead@bsigroup.com

Follow standard

You are now following this standard. Weekly digest emails will be sent to update you on the following activities:

You can manage your follow preferences from your Account. Please check your mailbox junk folder if you don't receive the weekly email.

Unfollow standard

You have successfully unsubscribed from weekly updates for this standard.

Error